Alzheimer's conference preview of emerging companies' research and commercialization strategies. Insightful context on pipelines and patient-care implications.
Key Takeaways
- Alzheimer's research is diversifying beyond amyloid, including neurotechnology and regenerative approaches
- Noninvasive Spectris stimulation increased brain lipid-transport protein levels
- Presentations emphasized real-world LEQEMBI use, at-home injections, and stem-cell Phase 2 findings